Finance

PRA Group Q2 2026 slides: record ERC drives earnings beat

https://www.investing.com/news/company-news/pra-group-q2-2026-slides-record-erc-drives-earnings-beat-93CH-4844829 Investing.com

Maravai Q2 2026 slides: margin expansion drives EBITDA guidance raise

https://www.investing.com/news/company-news/maravai-q2-2026-slides-margin-expansion-drives-ebitda-guidance-raise-93CH-4844830 Investing.com

Sezzle Q2 2026 slides: 52% revenue jump, but stock tumbles on outlook

https://www.investing.com/news/company-news/sezzle-q2-2026-slides-52-revenue-jump-but-stock-tumbles-on-outlook-93CH-4844832 Investing.com

Earnings call transcript: Astrana Health tops Q2 2026 profit forecasts

https://www.investing.com/news/transcripts/earnings-call-transcript-astrana-health-tops-q2-2026-profit-forecasts-93CH-4844780 Investing.com

Weight loss drug Wegovy made Novo Nordisk Europe’s most valuable company. Finding its next blockbuster drug is proving difficult 

is growing at a very rapid pace.”  JPMorgan Global Research forecasts that the market for GLP-1s and other weight-loss drugs will reach $200 billion by 2030....

Covista Q4 2026 slides: enrollment surges, margins expand sharply

https://www.investing.com/news/company-news/covista-q4-2026-slides-enrollment-surges-margins-expand-sharply-93CH-4844748 Investing.com

BioMarin Q2 2026 slides: Amicus deal drives 20% revenue growth

https://www.investing.com/news/company-news/biomarin-q2-2026-slides-amicus-deal-drives-20-revenue-growth-93CH-4844749 Investing.com

Latest articles

spot_imgspot_img